Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1999
10/21/1999WO1999053057A1 Protein and gene participating in the differentiation of immortalized cells
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053054A1 Axor4 g-protein-coupled receptor
10/21/1999WO1999053053A1 Gene coding for heliomicine and use thereof
10/21/1999WO1999053051A2 5' ests and encoded human proteins
10/21/1999WO1999053050A1 Methods and means for obtaining modified phenotypes
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053046A2 Noncloning technique for expressing a gene of interest
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053038A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053030A1 Method and system for managing immunocompetent cell batches for delayed use
10/21/1999WO1999053029A1 Method and system for managing batches of lymphocytes or monocytes for delayed use
10/21/1999WO1999053028A1 Pns cell lines and methods of use therefor
10/21/1999WO1999053026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053023A1 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts
10/21/1999WO1999053022A2 Selection of lineage specific cells after differentiation of progenitor cells
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999053016A2 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052943A1 T cell receptor expression cassette
10/21/1999WO1999052942A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052925A1 Programmed cell death and caspase-12
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052573A1 Encapsulation devices with strand, yarn or mesh core
10/21/1999WO1999052572A1 Methods and compositions for tissue regeneration
10/21/1999WO1999052544A2 Regulation of ovarian maturation and function using epidermal growth factor
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999WO1999052356A1 Creation of three-dimensional tissues
10/21/1999WO1999047102A3 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040114A9 Novel gabab receptor dna sequences
10/21/1999WO1999038988A3 A chemical inducible promoter used to obtain transgenic plants with a silent marker
10/21/1999WO1999036530A3 Lh-receptor gene promoter for tissue-specific gene expression
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999032643A3 Mood disorder gene
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999029279A3 Long-term survival and regeneration of central nervous system neurons
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999WO1998020932A3 Conditioning for allogeneic stem cell transplantation
10/21/1999DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2330104A1 Creation of three-dimensional tissues
10/21/1999CA2328461A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327516A1 Programmed cell death and caspase-12
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325560A1 Noncloning technique for expressing a gene of interest
10/21/1999CA2325344A1 Methods and means for obtaining modified phenotypes
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2325022A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
10/21/1999CA2325010A1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999CA2324992A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999CA2324988A1 Methods for treatment and prevention of infections
10/21/1999CA2324870A1 Modified biological material
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2323789A1 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
10/21/1999CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999CA2321181A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/20/1999EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999EP0950710A2 Cells expressing a chimera receptor and their uses
10/20/1999EP0950707A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950111A1 Methods using cre-lox for production of recombinant adeno-associated viruses
10/20/1999EP0950110A1 Novel morphogen-responsive signal transducer and methods of use thereof
10/20/1999EP0950107A1 Novel nucleic acid molecules from maize and their use for the production of modified starch
10/20/1999EP0950106A1 Agl15 sequences in transgenic plants
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950101A1 Secreted proteins and polynucleotides encoding them
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950099A1 NOVEL flt-3 RECEPTOR AGONISTS
10/20/1999EP0950095A2 TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950091A2 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
10/20/1999EP0950090A1 Serum-free cell culture media
1 ... 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 ... 1827